GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the catalytic domain of botulinum neurotoxin BONT/A C134S/C165S double mutant

Analyse Crystal structure of the catalytic domain of botulinum neurotoxin BONT/A… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4EL4
Type
protein
Length
425 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin a light chain
EC
3.4.24.69
UniProt
P10845
Ligands
ZN
Pockets
5 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin a light chain (EC 3.4.24.69)protein42532% helix, 18% strandP10845

Ligands and binding sites

  • ZN · Zinc ion · metal · chains A
  • GOL · Glycerol · additive · 2 copies · chains A
  • IMD · Imidazole · additive · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15350.700.7945IMD
2970.500.8215empty
3870.350.7517empty
4580.330.7714empty
5530.280.7512empty

Compared structures

  • 4EL4 · Crystal structure of the catalytic domain of botulinum neurotoxin BoNT/A C134S/C165S… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.